Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Outlook
    • Word
    • Excel
    • PowerPoint
    • OneNote
    • Sway
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

Calif. mass shooting
Teacher put on leave
Bond in DUI fatality
Buffalo child funeral
Prank gets destructive
Shanghai shops closed
Wants NATO assurances
Salmonella recall
Called by maid's name
Injured, withdraws
'Trendy' to be LGBTQ
No vax, no commissions
'Racist comment'
Interviewed together
Killed in bee swarm
8k-year-old skull
Half marathon death
NYC monkeypox case
'Zero emission' ring
Wars by drones, robots
Cleared in NYPD death
Cleared for last match
Several shot in Ind.
Shot baited bear
Scorching in Spain
Rare items auctioned
Looks outside China
Might run in 2024
Iconic baseball writer
Gas to Finland cut
US temperatures soar
New Australian PM
Filmmaking 'less fun'
Un-retiring for FCF
Wins Champions League
Greek Cup violence
PGA Championship
Heat vs Celtics Game 3
Legal action threat
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
39,000 results
Some report COVID symptoms after taking Pfizer’s Paxlovid. Here’s what we know
As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing ...
Global News
10d
Covid-19 rebound seen in some people after taking Pfizer drug Paxlovid
Pfizer’s Paxlovid can prevent severe covid-19 in vulnerable people when taken as a five-day course at home, but the medicine ...
New Scientist
3d
FDA to soon authorize Pfizer's COVID booster shot for younger kids: NYT
U.S. health regulators are expected to authorize a booster shot of Pfizer/BioNTech's COVID-19 vaccine for children aged 5 to ...
Tuoi Tre news
5d
Demand for Pfizer's COVID pills lags around the world
The Italian drug agency just started allowing general practitioners to prescribe Paxlovid in addition to specialists, which could increase use. Pfizer ... Canada needs a stronger COVID-19 ...
CTV News16d
Posts falsely claim Pfizer Covid-19 vaccine dangerous during pregnancy
The US Food and Drug Administration was ordered to comply with a Freedom of Information Act request to release thousands of ...
AFP Fact Check on MSN.com10d
Moderna seeks Health Canada approval for COVID-19 vaccine for kids under six
OTTAWA - The first COVID-19 vaccine for ... The U.S. Food and Drug Administration Friday said it would consider applications from both Moderna and Pfizer together possibly as early as June 8 ...
CP2422d
Pfizer recalls some batches of blood pressure drug over carcinogen presence
Pfizer Canada also recalled all lots of three doses of Accupril on ... Pfizer last month also recalled some batches of another blood pressure drug Accuretic and two authorized cheaper versions due to ...
Zawya29d
Moderna prepares to seek Health Canada COVID-19 vaccine approval for kids under 6
To date, Health Canada has only approved mRNA COVID-19 vaccines for children over the age of five. The Pfizer-BioNTech vaccine ... data to the Food and Drug Administration that it hopes will ...
The Star23d
Pfizer Recalls Some Batches Of Another Hypertension Drug Over Cancer-Causing Impurity
The drug giant said it was not aware of any reports ... in the U.S. and Puerto Rico from December 2019 to April 2022. Pfizer Canada also recalled all lots of three doses of Accupril on Thursday ...
Yahoo Finance26d
Pfizer Asks FDA To Authorize COVID-19 Booster Dose For Children 5 To 11 Years
(RTTNews) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) asked the U.S. Food and Drug Administration for emergency use authorization of a 10-microgram booster dose of their COVID-19 vaccine in ...
Nasdaq25d
FDA to authorize Pfizer's COVID booster shot for younger kids soon -NYT
The U.S. Food & Drug Administration is expected to authorize a booster shot of Pfizer/BioNTech's COVID-19 vaccine for ...
Investing.com
5d
© 2022 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback